----
Current ValuationThe current P/E ratio is 29.84, within the reasonable range, cheaper than 43.68% of the time in the past 1 years, and the industry ranks 17/74, the industry Median -0.02.
29.84xP/E
$12.80Stock price
$0.43Earnings per share
29.84xP/E
Stock price$12.80Earnings per share$0.43
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 29.19x
- Typical range
- 24.85x–32.50x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
08162432
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
CVSUSCVS Health | 23.91x | 393.80% | $116.91B |
LHUSLabcorp | 28.62x | 29.03% | $28.74B |
DGXUSQuest Diagnostics | 24.24x | 17.98% | $27.27B |
BTSGUSBrightSpring Health Services | 33.68x | 93.43% | $13.82B |
HNGEUSHinge Health | 25.17x | 129.83% | $9.43B |
CHEUSChemed | 27.62x | 21.43% | $7.80B |
OPCHUSOption Care Health | 22.71x | 18.20% | $4.76B |
CRVLUSCorVel | 36.20x | -- | $4.17B |
GRDNUSGuardian Pharmacy Services | 39.28x | 56.67% | $2.59B |
ADUSUSAddus Homecare | 22.44x | 17.66% | $2.36B |
VMDUSViemed Healthcare | 24.84x | 11.71% | $360.12M |
INFUUSInfusystem | 29.84x | 37.64% | $254.94M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
